GERD
Reflux to Esophageal Adenocarcinoma
- Publisher's listprice EUR 105.00
-
44 541 Ft (42 420 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 20% (cc. 8 908 Ft off)
- Discounted price 35 633 Ft (33 936 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
44 541 Ft
Availability
printed on demand
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher Elsevier Science
- Date of Publication 19 October 2006
- ISBN 9780123694164
- Binding Hardback
- No. of pages464 pages
- Size 276x215 mm
- Weight 1340 g
- Language English
- Illustrations Approx. 350 illustrations 0
Categories
Short description:
The increasing incidence of esophageal adenocarcinoma has created interest for research in this area. This work presents reflux carditis as a diagnostic criterion of GERD and defines the dilated end-stage esophagus and the earliest microscopic phase of GERD. It also outlines how gastroesophageal reflux causes cellular changes in the esophagus.
MoreLong description:
Gastroesophageal Reflux Disease (GERD) is one of the most common maladies of mankind. Approximately 40% of the adult population of the USA suffers from significant heartburn and the numerous antacids advertised incessantly on national television represents a $8 billion per year drug market. The ability to control acid secretion with the increasingly effective acid-suppressive agents such as the H2 blockers (pepcid, zantac) and proton pump inhibitors (nexium, prevacid) has given physicians an excellent method of treating the symptoms of acid reflux.
Unfortunately, this has not eradicated reflux disease. It has just changed its nature. While heartburn, ulceration and strictures have become rare, reflux-induced adenocarcinoma of the esophagus is becoming increasingly common. Adenocarcinoma of the esophagus and gastric cardia is now the most rapidly increasing cancer type in the Western world.
The increasing incidence of esophageal adenocarcinoma has created an enormous interest and stimulus for research in this area. GERD brings together a vast amount of disparate literature and presents the entire pathogenesis of reflux disease in one place. In addition to providing a new concept of how gastroesophageal reflux causes cellular changes in the esophagus, GERD also offers a complete solution to a problem that has confused physicians for over a century. Both clinical and pathological information about reflux disease and its treatment are presented. GERD is meant to be used as a comprehensive reference for gastroenterologists, esophageal surgeons, and pathologists alike.
Table of Contents:
Chapter 1: Overview of Gastroesophageal Reflux Disease
Chapter 2: The Past, Present, and Future of Columnar-Lined (Barrett) Esophagus
Chapter 3: Fetal Development of the Esophagus and Stomach
Chapter 4: Normal Anatomy; Present Definition of the Gastroesophageal Junction
Chapter 5: Histologic Definitions and Diagnosis of Epithelial Types
Chapter 6: Cardiac Mucosa
Chapter 7: New Histologic Definitions of Esophagus, Stomach, and Gastroesophageal Junction
Chapter 8: Pathology of Reflux Disease at a Cellular Level: Part 1-Damage to Squamous Epithelium and Transformation into Cardiac Mucosa
Chapter 9: The Pathology of Reflux Disease at a Cellular Level: Part 2-Evolution of Cardiac Mucosa to Oxyntocardiac Mucosa and Intestinal Metaplasia
Chapter 10: Pathology of Reflux Disease at a Cellular Level: Part 3-Intestinal (Barrett) Metaplasia to Carcinoma
Chapter 11: Pathology of Reflux Disease at an Anatomic Level
Chapter 12: Reflux Disease Limited to the Dilated End-Stage Esophagus: The Pathologic Basis of NERD
Chapter 13: Definition of Gastroesophageal Reflux Disease and Barrett Esophagus
Chapter 14: Diagnosis of Gastroesophageal Reflux Disease, Barrett Esophagus, and Dysplasia
Chapter 15: Research Strategies for Preventing Reflux-Induced Adenocarcinoma
Chapter 16: Rationale for Treatment of Reflux Disease and Barrett Esophagus
Chapter 17: Treatment Strategies for Preventing Reflux-Induced Adenocarcinoma
Index
More
